9/10/2026
FDA outlines new psychedelic drug framework in NEJM
The FDA highlights its evolving approach to psychedelic therapies amid a mental health crisis.
Topic archive
psychedelic drugs
9 stories
8/20/2026
Trump's FDA pick linked to Joe Rogan-backed psychedelic policy
Dr. Heidi Overton, nominated by Trump, expedited psychedelic research policy.
8/19/2026
Trump supports psychedelic drugs for veterans' mental health
Former President Trump advocates for psychedelic treatment to aid veterans.
8/19/2026
Trump highlights ibogaine in executive order on psychedelics
The executive order aims to expedite research on ibogaine and other psychedelics.
8/18/2026
University of Miami gifts ibogaine application to FDA
The move aims to expedite ibogaine research under a new executive order.
8/5/2026
Barrow Neurological Institute receives $5M for ibogaine study
Grant supports research into ibogaine's effects on neurological disorders.
7/24/2026
Joe Rogan's ibogaine advocacy sparks White House tension
Rogan's push for ibogaine approval led to conflict with a key Trump aide.
7/19/2026
Psychedelic drugs market sees positive growth signal
Investment interest grows in psychedelics for mental health treatment.
7/16/2026
San Antonio mayor advocates for ibogaine trials
Mayor Gina Ortiz Jones pushes for psychedelic trials to aid veterans.